Adrenalectomy in ectopic Cushing's syndrome: A retrospective cohort study from a tertiary care centre.


Journal

Journal of neuroendocrinology
ISSN: 1365-2826
Titre abrégé: J Neuroendocrinol
Pays: United States
ID NLM: 8913461

Informations de publication

Date de publication:
12 2021
Historique:
revised: 06 08 2021
received: 29 04 2021
accepted: 10 08 2021
pubmed: 28 8 2021
medline: 22 3 2022
entrez: 27 8 2021
Statut: ppublish

Résumé

Neuroendocrine neoplasms (NENs) causing ectopic Cushing's syndrome (ECS) are rare and challenging to treat. In this retrospective cohort study, we aimed to evaluate different approaches for bilateral adrenalectomy (BA) as a treatment option in ECS. Fifty-three patients with ECS caused by a NEN (35 females/18 men; mean ± SD age: 53 ± 15 years) were identified from medical records. Epidemiological and clinical parameters, survival, indications for surgery and timing, as well as duration of surgery, complications and surgical techniques, were collected and further analysed. The primary tumour location was thorax (n = 30), pancreas (n = 14) or unknown (n = 9). BA was performed in 37 patients. Median time from diagnosis of ECS to BA was 2 months (range 1-10 months). Thirty-two patients received different steroidogenesis inhibitors before BA to control hypercortisolaemia. ECS resolved completely after surgery in 33 patients and severe peri- or postoperative complications were detected in 12 patients. There were fewer severe complications in the endoscopic group compared to open surgery (p = .030). Posterior retroperitoneoscopic BA performed simultaneously by a two surgeon approach had the shortest operating time (p = .001). Despite the frequent use of adrenolytic treatment, BA was necessary in a majority of patients to gain control over ECS. Complication rate was high, probably as a result of the combination of metastatic disease and metabolic disorders caused by high cortisol levels. The two surgeon approach BA may be considered as the method of choice in ECS compared to other BA approaches as a result of fewer complications and a shorter operating time.

Identifiants

pubmed: 34448524
doi: 10.1111/jne.13030
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13030

Informations de copyright

© 2021 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.

Références

Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing's syndrome. Lancet (London, England). 2015;386(9996):913-927.
Alexandraki KI, Grossman AB. The ectopic ACTH syndrome. Rev Endocr Metab Disord. 2010;11(2):117-126.
Young J, Haissaguerre M, Viera-Pinto O, Chabre O, Baudin E, Tabarin A. Management of endocrine disease: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinion. Eur J Endocrinol. 2020;182(4):R29-R58.
Lase I, Strele I, Gronberg M, Kozlovacki G, Welin S, Janson ET. Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome. 2020.
Davi’ MV, Cosaro E, Piacentini S, et al. Prognostic factors in ectopic Cushing’s syndrome due to neuroendocrine tumors: a multicenter study. Eur J Endocrinol. 2017;176(4):453-461.
Nieman LK, Biller BMK, Findling JW, et al. Treatment of cushing's syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(8):2807-2831.
Chan C, Roberts JM. Ectopic ACTH syndrome complicated by multiple opportunistic infections treated with percutaneous ablation of the adrenal glands. BMJ Case Rep. 2017;2017:580.
Zener R, Zaleski A, Van Uum SH, Gray DK, Mujoomdar A. Successful percutaneous CT-guided microwave ablation of adrenal gland for ectopic Cushing syndrome. Clin Imaging. 2016;42:93-95.
Maxwell AWPMD, D’Amico KCMD, Dupuy DEMD. Microwave ablation as primary treatment for a central adrenocorticotropic hormone-secreting pulmonary carcinoid tumor in a patient with severe cushing syndrome. J Vasc Interv Radiol. 2016;27(11):1763-1765.
Sarma A, Shyn PB, Vivian MA, et al. Single-Session CT-guided percutaneous microwave ablation of bilateral adrenal gland hyperplasia due to ectopic ACTH syndrome. Cardiovasc Intervent Radiol. 2015;38(5):1335-1338.
Young H. Technique for simultaneous exposure and operation on adrenals. Surgery. 1936;63(119).
Gagner M, Lacroix A, Bolte E. Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma. N Engl J Med. 1992;327(14):1033.
Higashihara E, Tanaka Y, Horie S, et al. A case report of laparoscopic adrenalectomy. Japanese J Urol. 1992;83(7):1130-1133.
Guerin C, Taieb D, Treglia G, et al. Bilateral adrenalectomy in the 21st century: When to use it for hypercortisolism? Endocr Relat Cancer. 2016;23(2):R131-R142.
Walz MK, Peitgen K, Krause U, Eigler FW. Dorsal retroperitoneoscopic adrenalectomy-a new surgical technique. Zentralbl Chir. 1995;120(1):53-58.
Vrielink OM, Engelsman AF, Hemmer PHJ, et al. Multicentre study evaluating the surgical learning curve for posterior retroperitoneoscopic adrenalectomy. British J Surgery. 2018;105(5):544-551.
Lowery AJ, Seeliger B, Alesina PF, Walz MK. Posterior retroperitoneoscopic adrenal surgery for clinical and subclinical Cushing’s syndrome in patients with bilateral adrenal disease. Langenbeck's Arch Surgery. 2017;402(5):775-785.
Lombardi CPMD, Raffaelli MMD, de Crea CMD, et al. ACTH-dependent Cushing syndrome: The potential benefits of simultaneous bilateral posterior retroperitoneoscopic adrenalectomy. Surgery. 2011;149(2):299-300.
Raffaelli M, Brunaud L, De Crea C, et al. Synchronous bilateral adrenalectomy for Cushing's syndrome: laparoscopic versus posterior retroperitoneoscopic versus robotic approach. World J Surg. 2014;38(3):709-715.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-213.
Hellman P, Linder F, Hennings J, et al. Bilateral adrenalectomy for ectopic Cushing's syndrome - Discussions on technique and indication. World J Surg. 2006;30(5):909-916.
Porpiglia F, Terzolo M, Fiori C, et al. Bilateral adrenalectomy for Cushing's syndrome: a comparison between laparoscopy and open surgery. J Endocrinol Invest. 2004;27(7):654-658.
Reincke M, Ritzel K, Oßwald A, et al. A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome. Eur J Endocrinol. 2015;173(4):M23-M32.
Grossman A, Johannsson G, Quinkler M, Zelissen P. Therapy of endocrine disease: perspectives on the management of adrenal insufficiency: clinical insights from across Europe. Eur J Endocrinol. 2013;169(6):R165-175.
Alberda WJ, van Eijck CHJ, Feelders RA, Kazemier G, de Herder WW, Burger JWA. Endoscopic bilateral adrenalectomy in patients with ectopic Cushing’s syndrome. Surg Endosc. 2012;26(4):1140-1145.
Szabo Yamashita T, Sada A, Bancos I, et al. Bilateral adrenalectomy: differences between cushing disease and ectopic ACTH-producing tumors. Ann Surg Oncol. 2020.
Ritzel K, Beuschlein F, Mickisch A, et al. Outcome of bilateral adrenalectomy in cushing's syndrome: a systematic review. J Clin Endocrinol Metab. 2013;98(10):3939-3948.
Vella A, Thompson GB, Grant CS, Van Heerden JA, Farley DR, Young WF Jr. Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab. 2001;86(4):1596-1599.
Morris LF, Harris RS, Milton DR, et al. Impact and timing of bilateral adrenalectomy for refractory ACTH-dependent cushing’s syndrome. Surgery. 2013;154(6):1174-1184.
Salameh JR, Borman KR, Varkarakis GM. Laparoscopic bilateral adrenalectomy for occult ectopic ACTH syndrome. J Laparoendosc Adv Surg Tech. 2008;18(1):52-55.
Li H, Yan W, Mao Q, et al. Role of adrenalectomy in ectopic ACTH syndrome. Endocr J. 2005;52(6):721-726.

Auteurs

Ieva Lase (I)

Department of Medical Sciences, Endocrine Oncology Unit, Uppsala University, Uppsala, Sweden.

Malin Grönberg (M)

Department of Medical Sciences, Endocrine Oncology Unit, Uppsala University, Uppsala, Sweden.

Olov Norlén (O)

Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Peter Stålberg (P)

Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Staffan Welin (S)

Department of Medical Sciences, Endocrine Oncology Unit, Uppsala University, Uppsala, Sweden.

Eva Tiensuu Janson (ET)

Department of Medical Sciences, Endocrine Oncology Unit, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH